This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
This federal contract award to Pacific Biosciences of California, Inc. is for the provision of the company's Sequel and Sequel II DNA/RNA sequencing systems, associated reagents, kits, and consumables to support genomic research initiatives across several U.S. government agencies, including the Department of Health and Human Services National Institutes of Health, Department of Agriculture, Food and Drug Administration, and Department of Defense. The $384,376.00 firm fixed-price purchase order...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order contract to Pacific Biosciences of California, Inc. to provide SEQUEL II SEQUENCING KIT 2.0 BUNDLE. The contract has a potential value of $118,381.00 and a completion date of December 31, 2022. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing systems. The company has...
This firm-fixed-price purchase order for $32,500.00 was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. to provide their Sequel and Sequel II DNA/RNA sequencing systems, reagent kits, consumables, and preventative maintenance services. This contract is not designated as a set-aside. Pacific Biosciences is a manufacturer of specialized scientific equipment and a major provider of sequencing...
This contract award to Pacific Biosciences of California, Inc. is for the provision of a PacBio Sequel System 8M Upgrade. The contract, valued at $220,000.00, was awarded on a firm fixed price basis by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The contract does not have a set-aside designation. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel...
This federal contract award was made by the National Human Genome Research Institute, a civilian agency, to Pacific Biosciences of California, Inc., a for-profit manufacturer of scientific equipment. The $84,000 firm-fixed price purchase order is for the delivery of Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and support services. Pacific Biosciences has established itself as a key supplier of specialized long-read sequencing solutions to...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a manufacturer of scientific equipment and reagents, for the provision of their Sequel and Sequel II DNA/RNA sequencing systems and associated consumables. The contract has a potential value of $197,441.19 and a completion date of October 12, 2017. Pacific Biosciences has fulfilled over $10 million in federal contracts with...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $63,600 firm fixed price purchase order to Pacific Biosciences of California, Inc. for COMP. SEQUEL II SRV CONTRACT W/O INSIGHT. As the award references sequencing services without insight, it can be inferred the contract is to provide next generation DNA sequencing capabilities to support NIH research initiatives. Pacific Biosciences will perform the sequencing work...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Pacific Biosciences of California, Inc. on July 19, 2018 for the provision of a PacBio Sequel DNA sequencer. The potential value of the contract is $337,500.00. Pacific Biosciences is a manufacturer and provider of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA...
The Department of Health and Human Services Food and Drug Administration awarded a $433,950.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to provide a DNA sequencer with accessories. The contract has no set-aside designation and was completed on August 29, 2019. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing. They have fulfilled over $10 million in federal contracts, including with the...
This federal contract award is for the supply and installation of a Sequel II DNA sequencing machine by Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment. The contract, valued at $522,500.00, was awarded on May 13, 2019 by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations. The contract is a firm-fixed price purchase order with a completion date of June 9, 2019. Pacific Biosciences has a history of providing sequencing instruments, reagents, and services to various U.S. government agencies, including the Department of Agriculture, Food and Drug Administration, Centers for Disease Control, and Department of Defense, totaling over $10 million in federal contracts and delivery orders. This award is not associated with a set-aside designation.